22 episodes

Very welcome to Theragnostic Talks by SAM Nordic, the one and only podcast about theragnostic. What is even theragnostic? And what does the future for it look like? In this podcast we will find out interesting science and get answers to curious questions by talking with true experts - clinicians, scientists and people from the industry.

And to guide you through these episodes – Annette Andrén and Gustav Widar.

Annette is driven by the transformation of science into value for patients. Her background as a chemical engineer - with focus on biochemistry - has led her to different positions such as country manager and market access director in the Nordics. She has been working both within a large variety of different therapy areas and with breakthrough treatments for inflammation and autoimmune diseases. What she likes the most is when she is able to help out in the identification of scientific opportunities for collaborations between Health care, Research and the Industry. She is currently senior medical science liaison at SAM Nordic.

Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it really benefits the patient care. A couple of years ago he changed from healthcare to industry, now medical science liaison at SAM Nordic.

Theragnostic Talks SAM Nordic

    • Health & Fitness
    • 5.0 • 2 Ratings

Very welcome to Theragnostic Talks by SAM Nordic, the one and only podcast about theragnostic. What is even theragnostic? And what does the future for it look like? In this podcast we will find out interesting science and get answers to curious questions by talking with true experts - clinicians, scientists and people from the industry.

And to guide you through these episodes – Annette Andrén and Gustav Widar.

Annette is driven by the transformation of science into value for patients. Her background as a chemical engineer - with focus on biochemistry - has led her to different positions such as country manager and market access director in the Nordics. She has been working both within a large variety of different therapy areas and with breakthrough treatments for inflammation and autoimmune diseases. What she likes the most is when she is able to help out in the identification of scientific opportunities for collaborations between Health care, Research and the Industry. She is currently senior medical science liaison at SAM Nordic.

Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it really benefits the patient care. A couple of years ago he changed from healthcare to industry, now medical science liaison at SAM Nordic.

    Ready for theragnostics 2.0?

    Ready for theragnostics 2.0?

    The world is on its way of taking a giant leap forward in the field of theragnostics. But are we ready for it? In this episode of Theragnostic Talks, we discuss readiness and the best way to raise awareness of theragnostics. How do we develop the field? And how do we expand the nuclear medicine practice to meet this challenge?
     
    Guests: Adj. Prof. Cristina Nanni, Prof. Andrei Iagaru, Prof. Louise Emmett, and Jeevan Virk, Head of RLT at Novartis.
    By: Gustav Widar, Medical Affairs Manager at SAM Nordic
    Contact us: podcast@samnordic.se
    For more information, visit: www.samnordic.se

    • 29 min
    What is it with FAPI?

    What is it with FAPI?

    What is it with FAPI and how does it work? In this episode of Theragnostic Talks, we take a closer look at the tracer that everyone’s talking about. The new theragnostic tracer targets the tumour environment and can be used for both the diagnosis and treatment of a wide range of different types of cancers. Explaining this are Dr. Wolfgang Fendler, Prof. Thomas Hope, Kim M. Pabst, and Silvi Telo.
     
    Guests: Dr. Wolfgang Fendler, Prof. Thomas Hope, Kim M. Pabst, and Silvi Telo.
    By: Gustav Widar, Medical Affairs Manager
    Contact us: podcast@samnordic.se
    For more information, visit: www.samnordic.se

    • 17 min
    Prostate cancer and PSMA

    Prostate cancer and PSMA

    How do we move forward with prostate imaging? In today’s episode of Theragnostic Talks, live from the EANM'22 Congress in Barcelona, we focus on PSMA-PET. How has PSMA-PET developed? Where are we regarding the diagnosis of prostate cancer? And how can we use PSMA-PET as a diagnostic tool for other forms of malignant tumours? Our thanks to Prof. Helle Damgaard Zacho, Dr. Daniela Oprea-Lager, and Simona Malaspina for sharing your expertise with us.
     
    Guests: Prof. Helle Damgaard Zacho, Dr. Daniela Oprea-Lager and Simona Malaspina.
    By: Gustav Widar, Medical Affairs Manager at SAM Nordic
    Contact us: podcast@samnordic.se
    For more information: www.samnordic.se

    • 22 min
    EANM, today and tomorrow

    EANM, today and tomorrow

    What is EANM? What have been the most burning questions through the years and in what ways do we want to move forward in this area? Theragnostic Talks will be live in Barcelona to talk with the leading experts in theragnostics. We start by taking a closer look at the journey that nuclear medicine has taken lately, and we will be doing this in the company of Prof. Jolanta Kunikowska, President of EANM, and Prof. Stefano Fanti, EANM Congress Chair.
    Guests: Prof. Jolanta Kunikowska and Prof. Stefano Fanti
    By: Gustav Widar, Medical Affairs Manager
    Contact us: podcast@samnordic.se
    For more information: www.samnordic.se

    • 18 min
    EAU 22 Special Edition

    EAU 22 Special Edition

    LuTectomy – LuPSMA in the very early stage of prostate cancer – what were the initial results? What difference does it make, choosing the right PSMA tracer? And how should PSMA-PET be used, according to the radiation oncologist? Listen to our eminent guests Declan Murphy, Stefano Fanti, Louise Emmett, Gert de Meerleer and Ken Herrmann talking about the future of theragnostics in urology, from the EAU 22 Congress in Amsterdam.
     
    Guests: Ken Herrmann, Gert de Meerleer, Louise Emmett, Stefano Fanti and Declan Murphy.
    By: Lisa Gruschy and Gustav Widar
    Contact us: podcast@samnordic.se
    For more info, visit www.samnordic.se

    • 52 min
    Unlocking the potential of biomarkers in cancer treatment

    Unlocking the potential of biomarkers in cancer treatment

    Using biomarkers from a blood test: can that optimize the treatment for prostate cancer? Listen to Professor Henrik Grönberg, who recently received the award “Cancer Researcher of the Year in 2022” by the Swedish Cancer Society. He tells us about the ProBio study which has the potential to revolutionize the treatment of prostate cancer.
    Guest: Professor Henrik Grönberg
    By: Annette Andrén and Gustav Widar
    Contact us: podcast@samnordic.se
    For more info, visit www.samnordic.se

    • 35 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Ten Percent Happier
Kathryn Nicolai
Aubrey Gordon & Michael Hobbes
Dr. Mark Hyman

You Might Also Like